SGHT

Sight Sciences (SGHT)

Sight Sciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SGHT

1 2 3 4 5 6 7 8 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/30	22 : 19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SGHT	Sight Sciences Inc
2024/05/29	05 : 05	GlobeNewswire Inc.	Sight Sciences Announces the Publication of Twelve-Month Results of the SAHARA RCT Demonstrating Improved Signs and Symptoms of Dry Eye Disease for TearCare Patients Crossed Over from Restasis	NASDAQ:SGHT	Sight Sciences Inc
2024/05/28	21 : 30	GlobeNewswire Inc.	Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Pressure and Medication Reductions Achieved with OMNI® Across Mild, Moderate, and Advanced Glaucoma	NASDAQ:SGHT	Sight Sciences Inc
2024/05/21	09 : 56	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SGHT	Sight Sciences Inc
2024/05/18	05 : 16	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:SGHT	Sight Sciences Inc
2024/05/08	05 : 05	GlobeNewswire Inc.	Sight Sciences to Present at the Upcoming Bank of America Healthcare Conference	NASDAQ:SGHT	Sight Sciences Inc
2024/05/07	05 : 16	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SGHT	Sight Sciences Inc
2024/05/03	05 : 05	GlobeNewswire Inc.	Sight Sciences Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Financial Guidance	NASDAQ:SGHT	Sight Sciences Inc
2024/04/29	21 : 05	GlobeNewswire Inc.	Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma Surgery	NASDAQ:SGHT	Sight Sciences Inc
2024/04/19	05 : 05	GlobeNewswire Inc.	Sight Sciences to Report First Quarter Financial Results on May 2, 2024	NASDAQ:SGHT	Sight Sciences Inc
2024/04/11	05 : 05	GlobeNewswire Inc.	Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2	NASDAQ:SGHT	Sight Sciences Inc
2024/04/03	05 : 05	GlobeNewswire Inc.	Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting	NASDAQ:SGHT	Sight Sciences Inc
2024/03/27	05 : 05	GlobeNewswire Inc.	Sight Sciences to Present at the Upcoming 23rd Annual Needham Healthcare Conference	NASDAQ:SGHT	Sight Sciences Inc
2024/03/08	06 : 05	GlobeNewswire Inc.	Sight Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Initiates Full Year 2024 Financial Guidance	NASDAQ:SGHT	Sight Sciences Inc
2024/02/23	06 : 05	GlobeNewswire Inc.	Sight Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024	NASDAQ:SGHT	Sight Sciences Inc
2024/02/17	11 : 40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SGHT	Sight Sciences Inc
2024/02/17	11 : 40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SGHT	Sight Sciences Inc
2024/02/17	11 : 40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SGHT	Sight Sciences Inc
2024/02/17	11 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SGHT	Sight Sciences Inc
2024/02/17	11 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SGHT	Sight Sciences Inc
2024/02/17	11 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SGHT	Sight Sciences Inc
2024/02/17	11 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SGHT	Sight Sciences Inc
2024/02/17	11 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SGHT	Sight Sciences Inc
2024/02/17	11 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SGHT	Sight Sciences Inc
2024/02/17	11 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SGHT	Sight Sciences Inc
2024/02/17	11 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SGHT	Sight Sciences Inc
2024/02/17	11 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SGHT	Sight Sciences Inc
2024/02/17	11 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SGHT	Sight Sciences Inc
2024/02/17	11 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SGHT	Sight Sciences Inc
2024/02/17	11 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SGHT	Sight Sciences Inc